**Question:** The definition of extensively drug resistant TB includes resistance to all of the following drugs, EXCEPT:

A. Isoniazid
B. Ethambutol
C. Rifampicin
D. Pyrazinamide

**Core Concept:**

Extensively drug-resistant tuberculosis (XDR-TB) is a severe form of multidrug-resistant tuberculosis (MDR-TB), which is resistant to at least rifampicin and isoniazid (two of the most potent first-line anti-TB drugs). The World Health Organization (WHO) defines XDR-TB as resistance to at least one injectable drug (e.g., aminoglycosides) and a fluoroquinolone in addition to resistance to rifampicin and isoniazid.

**Why the Correct Answer is Right:**

The correct answer is **D. Pyrazinamide**, as it is not included in the definition of MDR-TB or XDR-TB. Pyrazinamide is a first-line drug primarily used for its bactericidal effect against Mycobacterium tuberculosis, particularly during the initial phase of treatment. However, it is not a critical component of resistance classification.

**Why Each Wrong Option is Incorrect:**

A. **Isoniazid**: This is a key component of the MDR-TB definition, indicating resistance to one of the most potent first-line drugs.
B. **Ethambutol**: Although ethambutol is not a key component of the resistance classification, resistance to this drug is not the criteria for XDR-TB classification.
C. **Rifampicin**: Resistance to rifampicin is a crucial component of MDR-TB classification, which is a prerequisite for XDR-TB classification.

**Clinical Pearl:**

The recognition of extensively drug-resistant tuberculosis is crucial for effective treatment planning and patient management, as these strains are often associated with severe disease progression and higher mortality rates. Adequate knowledge of drug resistance classification helps guide treatment options and patient prognosis.

In summary, understanding the specific drugs involved in the classification of drug-resistant tuberculosis is essential for accurate diagnosis and appropriate treatment planning.